Xue-Jia Lin
Overview
Explore the profile of Xue-Jia Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
1289
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie Y, Huang Y, Li Z, Jiang W, Shi N, Lu Y, et al.
Mol Cancer
. 2024 May;
23(1):95.
PMID: 38720319
Background: Dysregulation of immune surveillance is tightly linked to the development of metabolic dysfunction-associated steatohepatitis (MASH)-driven hepatocellular carcinoma (HCC); however, its underlying mechanisms remain unclear. Herein, we aimed to determine...
2.
Zhu L, Xia X, Li G, Zhu C, Li Q, Wang B, et al.
Cell Rep
. 2023 Aug;
42(8):112910.
PMID: 37531255
Amino acid (aa) metabolism is closely correlated with the pathogenesis of psoriasis; however, details on aa transportation during this process are barely known. Here, we find that SLC38A5, a sodium-dependent...
3.
Pan C, Tang H, Wang W, Wu D, Luo H, Xu L, et al.
Front Oncol
. 2023 Feb;
12:1077477.
PMID: 36733353
Background: Programmed death ligand 1 (PD-L1) and tumor mutation burden (TMB) have been developed as biomarkers for the treatment of immune checkpoint inhibitors (ICIs). However, some patients who are TMB-high...
4.
Li Z, Xie Y, Deng M, Zhu L, Wu X, Li G, et al.
Cancer Lett
. 2021 Nov;
526:322-334.
PMID: 34767926
The relationship between microRNA (miRNA) and hosting long non-coding RNA (lncRNA) remains unclear. Here, the expression levels of microRNA-210 (miR-210) and hosting lncRNA MIR210HG are significantly increased and positively correlated...
5.
Zhou Y, Bastian I, Long M, Dow M, Li W, Liu T, et al.
Proc Natl Acad Sci U S A
. 2021 Feb;
118(8).
PMID: 33602823
Many cancers evade immune rejection by suppressing major histocompatibility class I (MHC-I) antigen processing and presentation (AgPP). Such cancers do not respond to immune checkpoint inhibitor therapies (ICIT) such as...
6.
Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin X, et al.
Nature
. 2018 Jul;
560(7717):198-203.
PMID: 30046112
Dysregulated NLRP3 inflammasome activity results in uncontrolled inflammation, which underlies many chronic diseases. Although mitochondrial damage is needed for the assembly and activation of the NLRP3 inflammasome, it is unclear...
7.
Shalapour S, Lin X, Bastian I, Brain J, Burt A, Aksenov A, et al.
Nature
. 2018 Jul;
561(7721):E1.
PMID: 29973714
In this Article, the sentence: "After 7 months of HFD, MUP-uPA mice developed HCC, which contained numerous (usually 50-100 per tumour) non-recurrent coding mutations in pathways that are mutated in...
8.
Lin X, Fang J, Yang X, Zhang C, Yuan Y, Zheng L, et al.
Mol Ther Nucleic Acids
. 2018 Jun;
11:243-252.
PMID: 29858059
We previously found that 19 microRNAs (miRNAs) significantly increased in the sera of hepatocellular carcinoma (HCC) patients. Here, we evaluated whether these miRNAs were secreted by HCC cells and contributed...
9.
Shalapour S, Lin X, Bastian I, Brain J, Burt A, Aksenov A, et al.
Nature
. 2017 Nov;
552(7685):430.
PMID: 29168501
This corrects the article DOI: 10.1038/nature24302.
10.
Shalapour S, Lin X, Bastian I, Brain J, Burt A, Aksenov A, et al.
Nature
. 2017 Nov;
551(7680):340-345.
PMID: 29144460
The role of adaptive immunity in early cancer development is controversial. Here we show that chronic inflammation and fibrosis in humans and mice with non-alcoholic fatty liver disease is accompanied...